MengXuWelliverMDPh.D.
Radiation Oncology • Rochester, MNHematologic Malignancies, Sarcoma, Thoracic Cancer
Associate Professor of Radiation Oncology Senior Associate Consultant
Dr. Welliver is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 first St SW
Radiation Oncology
Rochester, MN 55905Phone+1 507-284-3261
Summary
- Dr. Meng Welliver is a radiation oncologist at Mayo Clinic, Rochester, MN. She moved to Mayo from Columbus Ohio where she worked for the Ohio State University James Cancer Hospital and Solove Research Institute as well as Ohio State University Wexner Medical Center. She received her MD, Ph.D. training from Pennsylvania State University College of Medicine, and residency training from University of Pennsylvania. She has been in practice for 14 years. She specializes in soft tissue sarcoma, bone sarcoma, thoracic cancers, and hematologic malignancies. She is experienced in clinical and translational investigation. She has more than 80 publications and over 2500 citations.
Education & Training
University of Pennsylvania Health SystemResidency, Radiation Oncology, 2007 - 2011- University of Pennsylvania Health SystemInternship, Internal Medicine, 2006 - 2007
Pennsylvania State University College of MedicineClass of 2006
Certifications & Licensure
MN State Medical License 2023 - 2025
OH State Medical License 2011 - 2025
WI State Medical License 2024 - 2025
MS State Medical License 2021 - 2022
PA State Medical License 2006 - 2016- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2013 Oct 28
- Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies Start of enrollment: 2015 Jul 27
- Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
Publications & Presentations
PubMed
- 1 citationsA Phase 2 Trial of Primary Tumor Stereotactic Body Radiation Therapy Boost Before Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer.Terence M Williams, Eric Miller, Meng Welliver, Jeremy Brownstein, Gregory Otterson
International Journal of Radiation Oncology, Biology, Physics. 2024-11-01 - Outcomes of non-angiosarcoma radiation-associated soft tissue sarcomas of the chest.Leilani Garayua-Cruz, Samuel E Broida, Scott H Okuno, Steven I Robinson, Brittany L Siontis
Journal of Surgical Oncology. 2024-07-01 - A Case of Mediastinal Carcinosarcoma With Beta-HCG Production and KRAS Mutation.Nada Shaker, Chiemezie C Amadi, Meng Welliver, Gregory A Otterson, David A Liebner
International Journal of Surgical Pathology. 2023-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
